Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

NCT01253642 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped low enrollment

Conditions

Hormone-Resistant Prostate Cancer
Metastatic Prostatic Adenocarcinoma
Prostate Adenocarcinoma
Recurrent Prostate Carcinoma

Interventions

PROCEDURE: Biopsy of Prostate
DRUG: Docetaxel
OTHER: Laboratory Biomarker Analysis
DRUG: Phenelzine Sulfate

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]